“Israeli companies that have overlooked the UK as a trial site, now can take advantage of streamlined access that is being offered locally by the UK Israel Tech Hub and in the UK by a new agency, NOCRI, the NIHR Organization for Clinical Research Infrastructure in the UK,” says Iris Geffen Gloor, the Biomed Manager of the UK Israel Tech Hub.
“Time can often be the most expensive factor in conducting a clinical trial,” explains Iris Geffen Gloor. “NOCRI now provides rapid access to clinical investigators, patient recruitment, data gathering and the world-class UK research infrastructure.”
On November 7-8 in
NOCRI Managing Director Mark Samuels will lead the seminar (see feature story) which will take place in Ramat Gan.
The event is being hosted by the UK Israel Tech Hub at The British Embassy, together with UKTI.
The UK Israel Tech Hub at the British Embassy Israel (the “Hub”) was set up a year ago to promote a UK – Israel partnership in technology.
“The Israeli tech scene has had a strong synergetic relationship with the US for many years. This model can be viewed as benchmark for win/win relations between two economies, which can be replicated and adapted to the UK market,” says Iris Geffen Gloor.
She points out that the UK offers many advantages for collaborating and the locally-based Hub staff are tailoring the unique strengths of companies in each country to match each other.
To participate contact Iris Geffen Gloor, Biomed Manager, UK Israel Tech Hub@ The British Embassy in Israel iris@UKIsraelHub.com